4//SEC Filing
Mamluk Roni 4
Accession 0000899243-21-008055
CIK 0001797336other
Filed
Feb 23, 7:00 PM ET
Accepted
Feb 24, 5:42 PM ET
Size
7.8 KB
Accession
0000899243-21-008055
Insider Transaction Report
Form 4
Mamluk Roni
DirectorCEO
Transactions
- Sale
Common Stock
2021-02-22$19.86/sh−15,200$301,813→ 163,271 total - Sale
Common Stock
2021-02-24$17.40/sh−10,800$187,919→ 145,345 total - Sale
Common Stock
2021-02-23$17.89/sh−7,126$127,483→ 156,145 total
Footnotes (1)
- [F1]The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan.
Documents
Issuer
Ayala Pharmaceuticals, Inc.
CIK 0001797336
Entity typeother
Related Parties
1- filerCIK 0001647053
Filing Metadata
- Form type
- 4
- Filed
- Feb 23, 7:00 PM ET
- Accepted
- Feb 24, 5:42 PM ET
- Size
- 7.8 KB